Drugs / PS128
PS128
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04942522 | Jun 2021 → Jun 2023 | autism spectrum disorder | Yan Hao | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PS128 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04942522 ↗ |
| Known as | Probiotic PS128 | “Application of Probiotic PS128 (Lactobacillus Plantarum, PS128) in Children With Autism Spectrum Disorder (ASD)” NCT04942522 ↗ |
| Known as | probiotics PS128 | “Biological: probiotics PS128” NCT04942522 ↗ |
| Route | Oral | “one capsule orally twice daily for 8 weeks” NCT04942522 ↗ |